This course includes the webinar and CME/CMLE credit


This webinar will address current concepts in the realm of cell free DNA testing for cancer, with an emphasis on the role of plasma-based testing in patients with non small cell lung carcinoma. Topics to be covered include: the process for validating and implementing cfDNA testing in the hospital setting, the clinical role for cfDNA testing in cancer patients with an emphasis on EGFR-mutated lung carcinoma, and approaches to next generation sequencing for cfDNA.  Practical issues will be emphasized, including clinical performance characteristics of available assays and specimen handling considerations. Selected studies demonstrating the future potential of cfDNA testing for cancer monitoring will be reviewed.

Speaker: Lynette M. Sholl, MD

Host: Anthony Snow, MD

Duration: 1 hr

Level of Instruction: Basic

Last day to purchase course and claim credit: September 25, 2020

Maximum CME/CMLE credit available: 1.0

How to claim credit

To earn CME/CMLE credit, all learners must watch the webinar and then complete the online survey. To access the online survey, click "Submit credit" on the course homepage, or click on "My Credit" on the menu to the left.

AMA PRA Category 1 Credit(s)™

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of American Society for Clinical Pathology (ASCP) and Association for Molecular Pathology (AMP). The American Society for Clinical Pathology (ASCP) is accredited by the ACCME to provide continuing medical education for physicians.

The ASCP designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

This continuing medical laboratory education activity is recognized by the American Society for Clinical Pathology for 1.0 hours of CMLE credit. ASCP CMLE credit hours are acceptable for the ASCP Board of Certification (BOC) Certification Maintenance Program (CMP). CMLE credit hours meet the continuing education requirements for the ASCP Board of Certification Credential Maintenance Program (CMP) and state relicensure requirements for laboratory personnel. Participants should claim only the credit commensurate with the extent of their participation in the activity. 

* You may not submit SAMs and CME/CMLE credit for the same content.

Note: Join the AMP Family to purchase this content for a deep discount!

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

Course Information
Course Date:
September 25, 2017
Course Objectives
  • Identify the challenges of validation and implementation of cfDNA testing in the clinical laboratory.
  • Describe the utility and approach of targeted genotyping versus next generation sequencing from cfDNA.
  • Describe the clinical need for alternatives to tumor tissue testing and the current role for cell free DNA diagnostics in lung cancer.
  • Describe approaches to cfDNA assay design and validation.
Cell Free DNA Testing for Cancer: Clinical Validation, Implementation and Applications
Speaker Information
Lynette M. Sholl MD   [ view bio ]
Individual topic purchase: Selected
American Medical Association
Continuing Medical Education: 1.00
American Society for Clinical Pathology
CMLE: 1.00
Webinar + CME/CMLE
AMP Regular Member: $5.00
AMP Technologist Member: $5.00
AMP Associate Member: $5.00
Non-member Price: $205.00